ChemicalBook > Product Catalog >Pharmaceutical intermediates >Bulk Drug Intermediates >[2S-[2α(R*),3β]]-N-ForMyl-
[2S-[2α(R*),3β]]-N-ForMyl-
![[2S-[2α(R*),3β]]-N-ForMyl- Structure](CAS/GIF/104872-28-8.gif)
- CAS No.
- 104872-28-8
- Chemical Name:
- [2S-[2α(R*),3β]]-N-ForMyl-
- Synonyms
- D-Leucine Orlistat;(R,S,S,S)-Orlistat;Orlistat Impurity 47;Orlistat (R,S,S,S)-Isomer;2S-[2α(R*),3β]]-N-ForMyl-;[2S-[2α(R*),3β]]-N-ForMyl-;Orlistat Impurity 9(R,S,S,S);Orlistat Impurity 17(Orlistat(R,S,S,S)-Isomer);(S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)tridecan-2-yl formyl-D-leucinate;N-ForMyl-D-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]Methyl]dodecyl Ester
- CBNumber:
- CB42622138
- Molecular Formula:
- C29H53NO5
- Molecular Weight:
- 495.73
- MOL File:
- 104872-28-8.mol
- Modify Date:
- 2023/4/23 13:52:06
[2S-[2α(R*),3β]]-N-ForMyl- Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 34)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
SYNRYN PHARMA PVT LTD | +91 9392615244 | Telangana, India | 115 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
sgtlifesciences pvt ltd | +8617013299288 | China | 12382 | 58 | Inquiry |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 | China | 11927 | 58 | Inquiry |
Hefei fuya biotechnology co. LTD | 18096409024 | China | 1974 | 58 | Inquiry |
JiNan QiYuan Biotechnology Co., Ltd | 18766124282; 18766124282 | China | 743 | 58 | Inquiry |
TOSUN PHARM | 020-61855200 13326451905 | China | 7565 | 58 | Inquiry |
Hubei Shishun Biotechnology Co. Ltd | 027-59223025 15107168801 | China | 9943 | 58 | Inquiry |
Hubei Tuobang Chemical Co., Ltd. | 027-59106185 13986192185 | China | 9977 | 58 | Inquiry |
104872-28-8([2S-[2α(R*),3β]]-N-ForMyl-)Related Search:
Orlistat Dimer Impurity
(2S,3S,5S)-2-Hexyl-3,5-dihydroxyhexadecanoic Acid
Lipstatin
Orlistat Impurity 31
AHLBNYSZXLDEJQ-HDVRVJOHSA-N
(3S,4S)-3-Hexyl-4-[(S)-2-hydroxytridecyl]-2-oxetanone
N-FORMYL-L-LEUCINE
Orlistat Tetradecyl Ester
N-ForMyl-L-leucine [S-(E)]-1-(2-Nonenyl)dodecyl Ester
(S,S,R,S)-Orlistat
chevron_left
1of4
chevron_right
(R,S,S,S)-Orlistat
[2S-[2α(R*),3β]]-N-ForMyl-
N-ForMyl-D-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]Methyl]dodecyl Ester
D-Leucine Orlistat
2S-[2α(R*),3β]]-N-ForMyl-
Orlistat Impurity 17(Orlistat(R,S,S,S)-Isomer)
Orlistat (R,S,S,S)-Isomer
Orlistat Impurity 9(R,S,S,S)
(S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)tridecan-2-yl formyl-D-leucinate
D-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
Orlistat Impurity 47
104872-28-8
Amino Acids & Derivatives
Heterocycles
Impurities
Intermediates & Fine Chemicals
Pharmaceuticals